Molecular imaging in oncology

A S K Dzik-Jurasz1

  • 1GlaxoSmithKline, 891-995 Greenford Road, Middlesex, UB6 0HE, UK.

Insights

Molecular imaging aims to visualize cancer's molecular processes in vivo. Overcoming resolution limits requires collaboration between biologists, chemists, and imaging scientists for clinical success.

Area of Science:

  • Oncology
  • Molecular Biology
  • Medical Imaging

Background:

  • Cancer is a genetic disease involving the loss of cellular homeostasis.
  • Understanding molecular processes is key for developing cancer biomarkers and therapies.
  • Pharmaceutical investment drives the need for molecularly targeted treatments.

Purpose of the Study:

  • To highlight the role of molecular imaging in visualizing cancer's molecular underpinnings.
  • To identify challenges and requirements for advancing in vivo molecular imaging.
  • To emphasize the necessity of interdisciplinary collaboration for clinical translation.

Main Methods:

  • The abstract discusses the conceptual framework and challenges of molecular imaging.
  • It emphasizes the need for understanding molecular processes at the cellular level.
  • It highlights the limitations of current clinical imaging resolution for molecular targets.

Main Results:

  • Molecular processes in cancer occur at scales and concentrations challenging for current imaging.
  • Significant advancements are needed to bridge the gap between molecular events and imaging capabilities.
  • Interdisciplinary collaboration is crucial for overcoming these technical hurdles.

Conclusions:

  • Molecular imaging holds promise for understanding and treating cancer at its source.
  • Successful clinical implementation hinges on integrating expertise from molecular biology, chemistry, and imaging science.
  • Addressing resolution and sensitivity limitations is paramount for future molecular imaging applications in oncology.